Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial

There is no fulltext present in this item.

Title:	Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial
Author(s):	Raven, Stijn F.H.; Hoebe, C.J.P.A.; Vossen, A.C.T.M.; Visser, Leo G.; Hautvast, J.L.A. ; Roukens, Anna H.E.; Steenbergen, J.E. van
Publication year:	2020
Source:	Lancet Infectious Diseases, vol. 20, iss. 1, (2020), pp. 92-101
ISSN:	1473-3099
DOI:	https://doi.org/10.1016/S1473-3099(19)30417-7
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/214440
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Organization:	Primary and Community Care IQ Healthcare Radboudumc Extern
Journal title:	Lancet Infectious Diseases
Volume:	vol. 20
Issue:	iss. 1
Page start:	p. 92
Page end:	p. 101